Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 273-308-8 | CAS number: 68956-55-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Repeated dose toxicity: oral
Administrative data
- Endpoint:
- short-term repeated dose toxicity: oral
- Remarks:
- combined repeated dose and reproduction / developmental screening
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP, guideline study available as unpublished report, no restrictions, fully adequate for assessment.
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 992
- Report date:
- 1992
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Reference substance name:
- Penta-1,3-diene
- EC Number:
- 207-995-2
- EC Name:
- Penta-1,3-diene
- Cas Number:
- 504-60-9
- Molecular formula:
- C5H8
- IUPAC Name:
- penta-1,3-diene
- Reference substance name:
- 1,3-pentadiene
- IUPAC Name:
- 1,3-pentadiene
- Reference substance name:
- piperylene
- IUPAC Name:
- piperylene
- Details on test material:
- - Name of test material (as cited in study report): 1,3 Pentadiene (MRD-91-935)
- Physical state: pale yellow liquid
- Analytical purity: 98% (assumed 100% for dosing)
- Lot/batch No.: 1
- Storage condition of test material: room temperature
Constituent 1
Constituent 2
Constituent 3
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Breeding Laboratories, Inc., Kingston Facility, Stone Ridge, New York, USA
- Age at study initiation: 69 days (males), 76 days (females)
- Weight at study initiation: 345-407 g (males), 223-262 g (females)
- Housing: Single housed during the test period, except during mating and post-parturition, in suspended stainless steel and wire mesh cages.
- Diet: Purina Certified Rodent Chow (5002 Meal), ad libitum. Manufacturer: Purina Mills, Inc., Richmond, Indiana, USA.
- Water: Mains water ad libitum
- Acclimation period: 13 days
ENVIRONMENTAL CONDITIONS
- Temperature: 68-76°F
- Humidity: 40-70%
- Air changes (per hr): Not reported
- Photoperiod: 12hrs dark / 12hrs light
IN-LIFE DATES: From: 16 September 1991 To: 12 November 1991
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- PREPARATION OF DOSING SOLUTIONS:
The undiluted test material was thoroughly mixed with corn oil at the following concentrations to ensure a 5 mL/kg dose volume at all dose levels:
30 mg/kg = 0.6% (w/v); 100 mg/kg =2.0% (w/v); 1000 mg/kg = 20.0% (w/v). Dosing solutions were prepared every 2-5 days during the first 3 weeks of the study and weekly thereafter. - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Samples of MRD-91-935 in corn oil were analysed for stability, uniformity and achieved concentration by gas chromatography at intervals during the study and were found to be satisfactory.
- Duration of treatment / exposure:
- P1 animals were dosed daily for 2 weeks prior to mating and throughout the mating period for the F1 litter. P1 females additionally were dosed during gestation and until the day prior to euthanasia on or after postpartum Day (PPD) 4.
- Frequency of treatment:
- 7 days/week
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 30, 100, 1000 mg/kg day
Basis:
other: nominal in corn oil
- No. of animals per sex per dose:
- 12
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale: In a range-finding study rats were dosed with 0, 50, 500, and 1000 mg/kg. Treatment-related body weight gain suppression was seen. Therefore, the following dose levels were used: 30 mg/kg (anticipated to be the NOAEL), 100 and 1000 mg/kg.
Examinations
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: at least once daily
BODY WEIGHT: Yes
- Time schedule: Males - prior to prior to P1 selection, on the first day of dosing, and at least weekly thereafter until euthanasia. Females - prior to P1 selection, on the first day of dosing and at least weekly thereafter until mating was confirmed, then on GD 0, 7, 14, and 21 and on PPD 0 and 4.
FOOD CONSUMPTION: Yes
- Time schedule: P1 male on the first day of dosing and at least weekly thereafter, except during mating, until euthanized. Food consumption of P1 females on test Day 0 and at least weekly thereafter, except during mating, then on GD 0, 7, 14 and 21 and on PPD 0 and 4.
FOOD EFFICIENCY: No
WATER CONSUMPTION: No
OPHTHALMOSCOPIC EXAMINATION: No
HAEMATOLOGY: Yes
- Time schedule for collection of blood: At post mortem examination
- Animals fasted: Yes
- How many animals: All surviving P1 males
- Parameters examined: haematocrit, haemaglobin, erythrocyte count, leukocyte count (total and differential), platelet count, reticulocyte count (slides prepared but examined only if other RBC parameters abnormal), mean corpuscular volume, mean corpuscular haemoglobin, mean corpuscular haemoglobin concentration.
CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: At post mortem examination
- Animals fasted: Yes
- How many animals: All surviving P1 males
- Parameters examined: albumin, alkaline phosphatase, urea nitrogen, calcium, cholesterol, creatinine, electrolytes (Na+, Cl-, K+, CO2), gamma glutamyl transferase, glucose, phosphorus, alanine aminotransferase, aspartate aminotransferase, total protein, total bilirubin, triglycerides
URINALYSIS: No
NEUROBEHAVIOURAL EXAMINATION: No - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes
All adult animals, including those that died spontaneously. Body weights were recorded on the day of necropsy. The uterus of each female which failed to deliver a litter was examined for evidence of implantations. The number of implantation sites and corpora lutea were recorded at the time of necropsy for all dams with litters.
The following organs and tissues of all adult animals euthanized at study termination were weighed prior to fixation: liver, testes, thymus, kidneys, epididymides. Organ:body weight ratios were calculated.
All Fl pups which died were subjected to an external examination, including the palate. All live Fl pups were sexed and examined externally and weighed on the day of euthanasia. Offspring were discarded without further examination.
HISTOPATHOLOGY: Yes
The following tissues were examined from the controls and high dose animals only: brain, heart, spleen, kidneys, liver, adrenals, testes/epididymides, abnormal tissues. In addition, ovaries and thymus were fixed but not routinely processed. Ovaries from females which failed to complete pregnancy were examined histopathologically. - Statistics:
- mean body weights, food consumption, organ weights, relative organ weights and clinical laboratory findings: Bartlett's test of homogeneity of variance, followed by a standard one-way analysis of variance. If the ANOVA was significant, Dunnett's test was performed to determine which treated groups differed from the control. A linear regression to test for a dose response also was performed and tested for lack of fit to the regression. If the variances were not equivalent, then a Kruskal-Wallis (non-parametric) test was performed to determine if the treatment effects were equivalent. If there was a difference, Dunn's Summed Rank Test was used to determine which treatment groups differed from the control. Jonckheere's test for ordered response also was performed.
Results and discussion
Results of examinations
- Clinical signs:
- no effects observed
- Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- effects observed, treatment-related
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- no effects observed
- Clinical biochemistry findings:
- no effects observed
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Gross pathological findings:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
- Histopathological findings: neoplastic:
- no effects observed
- Details on results:
- CLINICAL SIGNS AND MORTALITY: There were no apparent trends in male or female in-life observations which were associated with treatment with the
test material. Mortality was limited to three high dose females which died spontaneously prior to mating; one of these deaths was due to a gavage accident
BODY WEIGHT AND WEIGHT GAIN: There were no biologically meaningful differences in mean body weights for either sex in treated groups when compared with controls at any interval during the study, including gestation and the postpartum period.
FOOD CONSUMPTION: A statistically significant decrease in mean food consumption was observed in high dose females on test Day 7 compared with that in controls.
HAEMATOLOGY: No remarkable differences observed between treated and control males.
CLINICAL CHEMISTRY: No remarkable differences observed between treated and control males.
ORGAN WEIGHTS: Mean absolute and relative organ weights in treated groups of both sexes were comparable with controls.
GROSS PATHOLOGY: Postmortem abnormalities were limited to incidental findings which were considered unrelated to treatment with the test material
HISTOPATHOLOGY: There were no treatment-related microscopic changes observed.
Effect levels
- Dose descriptor:
- NOAEL
- Effect level:
- 100 mg/kg bw/day (nominal)
- Sex:
- male/female
- Basis for effect level:
- other: transient decrease in food consumption in high dose (1000 mg/kg/day) females. No other treatment-related effects in parents or offspring
Target system / organ toxicity
- Critical effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- Treatment-related parental toxicity was limited to a transient decrease in food consumption in high dose (1000 mg/kg day) females. No other treatment-related effects were observed in parents or their offspring. The NOAEL for MRD-91-935 (1,3-pentadiene) was 100 mg/kg/day.
- Executive summary:
In a combined repeat dose and reproductive/developmental toxicity screening study with MRD-91-935 (1,3-pentadiene) in rats effects were limited to a transient decrease in food consumption in high dose (1000 mg/kg day) females. No other treatment-related effects were observed in parents or their offspring. The NOAEL (repeat dosing) for MRD-91-935 (1,3-pentadiene) was 100 mg/kg/day.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)